Related Experiment Video
Updated: Jun 15, 2026
06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
Refractory response to platelet transfusion therapy.
1Infusion Services, Seattle Cancer Care Alliance, Seattle, Washington 98109, USA. seisenbe@seattlecca.org
Summary
Platelet refractoriness, the failure to achieve a sufficient platelet boost after transfusion, is often caused by leukocyte contamination leading to antibody formation. Understanding these causes is crucial for prevention and management.
Area of Science:
- Hematology
- Transfusion Medicine
- Immunology
Background:
- Platelet transfusions are vital for managing bleeding disorders.
- A successful transfusion typically results in an expected posttransfusion increment.
- Platelet refractoriness, defined as failure to achieve an adequate increment, poses a clinical challenge.
Purpose of the Study:
- To identify and explain the primary causes of platelet refractoriness.
- To highlight the role of nursing in preventing and managing refractoriness.
- To underscore the importance of understanding factors affecting posttransfusion platelet increments.
Main Methods:
- Review of literature on platelet transfusion outcomes.
- Analysis of factors contributing to poor posttransfusion increments.
- Definition and diagnostic criteria for platelet refractoriness.
Main Results:
- Leukocyte contamination of platelet products is the most frequent cause of refractoriness.
- Leukocyte contamination can lead to the formation of human leukocyte antigen (HLA) antibodies.
- ABO incompatibility and human platelet antigen (HPA) systems are also implicated in refractoriness.
Conclusions:
- Nurses require knowledge of refractoriness causes for effective patient care.
- Preventing leukocyte contamination is key to avoiding HLA antibody formation.
- Addressing ABO and HPA incompatibilities is essential for optimizing transfusion efficacy.
Related Concept Videos
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
02:45Blood Transfusion and Agglutination
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...